Trials / Completed
CompletedNCT04956562
Effect of Sinovac on Survival in Intensive Care Unit
Effect of Inactivated COVID-19 Vaccine, Sinovac on Survival in Intensive Care Unit
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 96 (actual)
- Sponsor
- Sisli Hamidiye Etfal Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- —
Summary
Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience
Detailed description
Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine and declared a step by step inclusion schedule The primary aim of the study is to compare clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14 days before enrollment to the study with COVID-19 patients not vaccinated although they would have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2 infection with patients admitted to ICU before start of vaccination program.
Conditions
Timeline
- Start date
- 2021-04-01
- Primary completion
- 2021-05-15
- Completion
- 2021-05-15
- First posted
- 2021-07-09
- Last updated
- 2021-07-09
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04956562. Inclusion in this directory is not an endorsement.